When Grammy-nominated singer-songwriter Aloe Blacc got COVID despite being vaccinated and boosted, he tried to fund research for a better solution. What he quickly found out? You can’t just write a check in biotech. Regulators require a commercialization plan, and philanthropy doesn’t move science through clinical trials or get you a license on university IP. Now, he’s bootstrapping a cancer drug platform targeting pancreatic cancer, a disease that […]
Aloe Blacc’s fame means nothing in biotech (and that’s the point)
Originally reported by TechCrunch. Read the full story at the original source.
Related Articles
Fiona the Hippo Died After Eating a Hat. But How Does a Hat Kill a Hippo?
CommentLoaderSave StorySave this storyCommentLoaderSave StorySave this storyFiona, the Cincinnati Zoo’s famous hippo who...
Apple may be developing its own AI agent that runs your Mac
Apple appears to be working on its own AI agent to conduct computer work on behalf of users — including using apps, acce...
Anthropic’s 7 founders cashed out nearly $2B in record-breaking IPO
Anthropic became a public company on Thursday, raising a total of $81.3 billion including $1.95 billion for its seven fo...
Anthropic rival says companies can (mostly) skip the pricey models
On the same day that Anthropic went public in the largest IPO on record, with investor enthusiasm for the AI lab through...